Shadad Khallidi

Deputy director of policy, Health Canada (HC)1 communications in the past year

Lobbied by

Boehringer Ingelheim Canada

Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB). Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.

Recent activity

Nov 17, 2025

Mark Lewis contacted Shadad Khallidi on behalf of Boehringer Ingelheim Canada

Frequent lobbyist contacts

Mark LewisBoehringer Ingelheim Canada Ltd.1